News from NORD

FDA Commissioner to Present Keynote Address at NORD Summit


 

Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, will present the keynote address in the opening session of the 2017 NORD Summit. Dr. Gottlieb, who was sworn in as FDA Commissioner in May 2017, previously served as FDA’s Deputy Commissioner for Medical and Scientific Affairs. Before that, he was Senior Adviser to the FDA Commissioner.

Mike Porath, award-winning journalist and founder/CEO of The Mighty, will present the patient keynote. He has held writing, editing, and executive positions at ABC News, NBC News, the New York Times, and AOL. Mr. Porath is the father of a child with Dup15q syndrome and sits on the board of Dup15q Alliance.

Recommended Reading

Management of Poorly Controlled Indolent Systemic Mastocytosis Using Narrowband UVB Phototherapy
MDedge Dermatology
Muckle-Wells Syndrome in the Setting of Basal Cell Nevus Syndrome
MDedge Dermatology
Supportive care alone linked to worse outcomes in mucocutaneous reactions
MDedge Dermatology
Many aspects to caring for epidermolysis bullosa patients
MDedge Dermatology
Bone marrow transplantation for epidermolysis bullosa continues to evolve
MDedge Dermatology
Adalimumab for Hidradenitis Suppurativa
MDedge Dermatology
Precise cause of pityriasis rosea remains elusive
MDedge Dermatology
Care of infants with ichthyosis requires ‘all hands on deck’
MDedge Dermatology
Screening MRI misses Sturge-Weber in babies with port-wine stain
MDedge Dermatology
Preview Agenda for NORD’s 2017 Rare Diseases and Orphan Products
MDedge Dermatology